Table 1
Detailed information on 14 patients with topical MMC treatment
| Patient | Sex/age | Diagnosis | No of cycles | Epiphora | Lacrimal system findings | Other signs | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|
| MM, conjunctival malignant melanoma; PAM, primary acquired melanosis; SCC squamous cell carcinoma. | ||||||||
| 1 | M/49 | MM+PAM | 3 | Yes | Normal anatomy | Probing and syringing | Patent | |
| 2 | M/75 | MM+PAM | 1 | Yes | Normal anatomy | Probing and syringing | Patent | |
| 3 | M/83 | MM+PAM | 2 | Yes | Normal anatomy | Probing and syringing | Patent | |
| 4 | M/44 | MM+PAM | 1 | Yes | Common canalicular stenosis | Toxoallergic reaction | Silicon intubation 4 months | Patent |
| 5 | M/47 | MM+PAM | 3 | Yes | Lower canalicular obstruction | None | Patent upper canaliculus | |
| 6 | F/52 | MM+PAM | 5 | Yes | Punctum and canalicular stenosis | None | Watering | |
| 7 | M/56 | MM | 1 | Yes | Punctum stenosis | Probing and syringing | Patent | |
| 8 | M/71 | MM | 2 | Yes | Punctum stenosis | Silicon intubation 2 months | Patent | |
| 9 | F/63 | MM | 1 | Yes | Punctum stenosis | Silicon intubation 2 months | Patent | |
| 10 | M/62 | MM+PAM | 4 | No | Toxoallergic reaction | |||
| 11 | F/51 | PAM | 6 | No | ||||
| 12 | M/80 | MM | 1 | No | ||||
| 13 | M/49 | SCC | 5 | No | ||||
| 14 | F/85 | MM+PAM | 1 | No | ||||
